News Conference News EuroPCR 2023 Renal Denervation: Exploring Its Potential Beyond Hypertension Todd Neale May 18, 2023
News Conference News EuroPCR 2023 Two New Renal Denervation Systems Look Good in Uncontrolled BP Todd Neale May 17, 2023
News Features Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar L.A. McKeown May 12, 2023
News Daily News Tight Link Between Ambulatory BP and Mortality Affirmed in Revamped Analysis Todd Neale May 10, 2023
News Daily News Low-Dose Polypills Top Other Approaches for Initial BP Control: Meta-analysis Todd Neale April 26, 2023
News Daily News New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF L.A. McKeown April 19, 2023
News Daily News CV Risk Disparities by Race/Ethnicity Persist in Childhood Cancer Survivors Yael L. Maxwell April 13, 2023
News Daily News Inactivity Pandemic Poised to Undo CVD Prevention Advances Michael O'Riordan April 11, 2023
News Daily News Third-Trimester Preeclampsia Screening Still Worthwhile, Data Suggest Caitlin E. Cox April 11, 2023
News Daily News Brain Areas Identified Linking High BP and Cognitive Impairment Todd Neale March 31, 2023
News Conference News ACC 2023 Diabetic Patients in Middle East, Africa Overburdened by ASCVD Michael O'Riordan March 14, 2023
News Conference News ACC 2023 Keto Diet Linked to Hypercholesterolemia, Higher ASCVD Risk Shelley Wood March 08, 2023
News Conference News ACC 2023 HALO: Baxdrostat No Better Than Placebo in Uncontrolled Hypertension Todd Neale March 08, 2023
News Conference News CRT 2023 Renal Denervation in Black Patients: SYMPLICITY HTN 3 Reassures at 36 Months Yael L. Maxwell February 28, 2023
News Daily News European Societies Define Best Practices for Performing Renal Denervation Todd Neale February 21, 2023
News Daily News Longer-Term ASCVD Risk Assessment Best for Younger Patients Michael O'Riordan February 16, 2023